The Shandra Eisenga Human Cell and Tissue Product Safety Act aims to enhance public and healthcare provider awareness about the risks and benefits associated with human cell and tissue product transplants. The main objective is to ensure that both the public and healthcare professionals are better informed about organ and tissue donation, which can lead to improved health outcomes and safety in transplant procedures. Key provisions of the Act include the requirement for the Secretary of Health and Human Services to launch a national educational campaign.